A. Fagiolini and A. Cuomo, “Personalized treatment of depression based on the patient’s psychopatology: the case for intravenous or intramuscular trazodone in the acute treatment of depression with psychomotor agitation, irritability, or insomnia and the subsequent transition to extended-release Trazodone (Contramid®) ”, PSY, vol. 30, no. 4, Feb. 2025.